These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 9386111

  • 1. A novel strategy for myocardial protection using in vivo transfection of cis element 'decoy' against NFkappaB binding site: evidence for a role of NFkappaB in ischemia-reperfusion injury.
    Sawa Y, Morishita R, Suzuki K, Kagisaki K, Kaneda Y, Maeda K, Kadoba K, Matsuda H.
    Circulation; 1997 Nov 04; 96(9 Suppl):II-280-4; discussion II-285. PubMed ID: 9386111
    [Abstract] [Full Text] [Related]

  • 2. Nuclear factor-kappa B decoy attenuates neuronal damage after global brain ischemia: a future strategy for brain protection during circulatory arrest.
    Ueno T, Sawa Y, Kitagawa-Sakakida S, Nishimura M, Morishita R, Kaneda Y, Kohmura E, Yoshimine T, Matsuda H.
    J Thorac Cardiovasc Surg; 2001 Oct 04; 122(4):720-7. PubMed ID: 11581604
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of intimal hyperplasia after balloon injury in rat carotid artery model using cis-element 'decoy' of nuclear factor-kappaB binding site as a novel molecular strategy.
    Yoshimura S, Morishita R, Hayashi K, Yamamoto K, Nakagami H, Kaneda Y, Sakai N, Ogihara T.
    Gene Ther; 2001 Nov 04; 8(21):1635-42. PubMed ID: 11895002
    [Abstract] [Full Text] [Related]

  • 4. Intratumoral injection of oligonucleotides to the NF kappa B binding site inhibits cachexia in a mouse tumor model.
    Kawamura I, Morishita R, Tomita N, Lacey E, Aketa M, Tsujimoto S, Manda T, Tomoi M, Kida I, Higaki J, Kaneda Y, Shimomura K, Ogihara T.
    Gene Ther; 1999 Jan 04; 6(1):91-7. PubMed ID: 10341880
    [Abstract] [Full Text] [Related]

  • 5. Retroinfusion of NFkappaB decoy oligonucleotide extends cardioprotection achieved by CD18 inhibition in a preclinical study of myocardial ischemia and retroinfusion in pigs.
    Kupatt C, Wichels R, Deiss M, Molnar A, Lebherz C, Raake P, von Degenfeld G, Hahnel D, Boekstegers P.
    Gene Ther; 2002 Apr 04; 9(8):518-26. PubMed ID: 11948377
    [Abstract] [Full Text] [Related]

  • 6. Decoy against nuclear factor-kappa B attenuates myocardial cell infiltration and arterial neointimal formation in murine cardiac allografts.
    Suzuki J, Morishita R, Amano J, Kaneda Y, Isobe M.
    Gene Ther; 2000 Nov 04; 7(21):1847-52. PubMed ID: 11110417
    [Abstract] [Full Text] [Related]

  • 7. Transfection of NFkappaB-decoy oligodeoxynucleotides using efficient ultrasound-mediated gene transfer into donor kidneys prolonged survival of rat renal allografts.
    Azuma H, Tomita N, Kaneda Y, Koike H, Ogihara T, Katsuoka Y, Morishita R.
    Gene Ther; 2003 Mar 04; 10(5):415-25. PubMed ID: 12601396
    [Abstract] [Full Text] [Related]

  • 8. [Transfection of nuclear factor-kappaB decoy oligodeoxynucleotides prevents ischemic acute renal failure in rats].
    Cao CC, Ding XQ, Ou ZL, Liu CF, Li P, Wang L, Zhu CF.
    Zhonghua Yi Xue Za Zhi; 2003 Sep 25; 83(18):1597-602. PubMed ID: 14642117
    [Abstract] [Full Text] [Related]

  • 9. Transcription factor decoy for NFkappaB inhibits TNF-alpha-induced cytokine and adhesion molecule expression in vivo.
    Tomita N, Morishita R, Tomita S, Gibbons GH, Zhang L, Horiuchi M, Kaneda Y, Higaki J, Ogihara T, Dzau VJ.
    Gene Ther; 2000 Aug 25; 7(15):1326-32. PubMed ID: 10918504
    [Abstract] [Full Text] [Related]

  • 10. Suppressed severity of collagen-induced arthritis by in vivo transfection of nuclear factor kappaB decoy oligodeoxynucleotides as a gene therapy.
    Tomita T, Takeuchi E, Tomita N, Morishita R, Kaneko M, Yamamoto K, Nakase T, Seki H, Kato K, Kaneda Y, Ochi T.
    Arthritis Rheum; 1999 Dec 25; 42(12):2532-42. PubMed ID: 10615998
    [Abstract] [Full Text] [Related]

  • 11. A novel strategy of decoy transfection against nuclear factor-kappaB in myocardial preservation.
    Sakaguchi T, Sawa Y, Fukushima N, Nishimura M, Ichikawa H, Kaneda Y, Matsuda H.
    Ann Thorac Surg; 2001 Feb 25; 71(2):624-9; discussion 629-30. PubMed ID: 11235718
    [Abstract] [Full Text] [Related]

  • 12. Efficient in vivo gene transfer into the heart in the rat myocardial infarction model using the HVJ (Hemagglutinating Virus of Japan)--liposome method.
    Aoki M, Morishita R, Muraishi A, Moriguchi A, Sugimoto T, Maeda K, Dzau VJ, Kaneda Y, Higaki J, Ogihara T.
    J Mol Cell Cardiol; 1997 Mar 25; 29(3):949-59. PubMed ID: 9152856
    [Abstract] [Full Text] [Related]

  • 13. Efficient gene transfer method into the whole heart through the coronary artery with hemagglutinating virus of Japan liposome.
    Sawa Y, Kadoba K, Suzuki K, Bai HZ, Kaneda Y, Shirakura R, Matsuda H.
    J Thorac Cardiovasc Surg; 1997 Mar 25; 113(3):512-8; discussion 518-9. PubMed ID: 9081096
    [Abstract] [Full Text] [Related]

  • 14. Intravenous injection of oligodeoxynucleotides to the NF-kappaB binding site inhibits hepatic metastasis of M5076 reticulosarcoma in mice.
    Kawamura I, Morishita R, Tsujimoto S, Manda T, Tomoi M, Tomita N, Goto T, Ogihara T, Kaneda Y.
    Gene Ther; 2001 Jun 25; 8(12):905-12. PubMed ID: 11426330
    [Abstract] [Full Text] [Related]

  • 15. [Cardioprotection of recombinant human erythropoietin pretreatment on ischemia-reperfused hearts and mechanism thereof: experiment with rats].
    Liu XM, Jia Z, Zhou ZQ, Xu JG.
    Zhonghua Yi Xue Za Zhi; 2007 Sep 18; 87(35):2463-7. PubMed ID: 18067805
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Ex vivo transfer of nuclear factor-kappaB decoy ameliorates hepatic cold ischemia/reperfusion injury.
    Yoshizumi T, Ikeda Y, Kaneda Y, Sueishi K.
    Transplant Proc; 2009 Jun 18; 41(5):1504-7. PubMed ID: 19545666
    [Abstract] [Full Text] [Related]

  • 19. Transfection of nuclear factor-kappaB decoy oligodeoxynucleotide protects against ischemia/reperfusion injury in a rat epigastric flap model.
    Uemura T, Tsujii M, Akeda K, Iino T, Satonaka H, Hasegawa M, Sudo A.
    J Gene Med; 2012 Nov 18; 14(11):623-31. PubMed ID: 23080520
    [Abstract] [Full Text] [Related]

  • 20. Molecular strategy using cis-element 'decoy' of E2F binding site inhibits neointimal formation in porcine balloon-injured coronary artery model.
    Nakamura T, Morishita R, Asai T, Tsuboniwa N, Aoki M, Sakonjo H, Yamasaki K, Hashiya N, Kaneda Y, Ogihara T.
    Gene Ther; 2002 Apr 18; 9(8):488-94. PubMed ID: 11948373
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.